¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acromial end"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • end-bud
    ²¿¸®½Ï
  • end-diastolic
    È®À帻±â
  • end-diastolic pressure
    È®Àå±â¸»¾Ð·Â
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-foot
    Á¾¸»´ÜÃß
  • end-pressure
    Á¾¾Ð, Á¾¸»¾Ð
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
  • end-tidal
    È£ÈíÁ¾±â-
  • end-to-side anastomosis
    ³¡¿·¿¬°á(¼ú), ´ÜÃø¿¬°á(¼ú)
  • fixed end
    °íÁ¤¸»´Ü
  • free end saddle partial denture
    À¯¸®´Ü±¹¼ÒÀÇÄ¡
  • Krause¡¯s end bulb
    Å©¶ó¿ìÁ¦³¡¸Á¿ï
  • motor end organ
    ¿îµ¿Á¾¸»±â°ü
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • zero end-expiratory pressure
    ³¯¼û³¡¿µÁ¡¾Ð, È£±â¸»¿µÁ¡¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • end-brush
    Ãà»è³¡°¡Áö
  • end-bud
    ²¿¸®½Ï
  • end-foot
    (¢¡bouton terminal) Á¾¸»´ÜÃß
  • end-pressure
    Á¾¾Ð, Á¾¸»¾Ð
  • end group
    ¸»´Ü±â
  • end organ
    Á¾¸»±â°ü
  • end product
    ÃÖÁ¾»ê¹°
  • end dilution value
    ü¿ÜÈñ¼®Ä¡
  • end group spine
    ±ê³¡°¡½Ã
  • end plate potential
    Á¾ÆÇÀüÀ§, Á¾¸»ÆÇÀüÀ§
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
  • miniature end plate potential
    ²¿¸¶Á¾¸»ÆÇÀü¾Ð, ¹Ì¼¼Á¾¸»ÆÇÀüÀ§
  • motor end organ
    ¿îµ¿Á¾¸»±â°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
  • hair on end pattern
    °ïµÎ¼± ¸ð¹ß ÇüÅÂ
  • positive end expiratory pressure =PEE
    È£±â¸»¾ç¾Ð.
  • positive end expiratory pressure =PEEP
    È£±â¸»¾ç¾Ð.
  • proximal end
    ±ÙÀ§´Ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
  • double-end graft
    ½Ö´ÜÀ̽Ä.
  • end apparatus
    Á¾¸»ÀåÄ¡(ðûØÇíûöÇ).
  • end artery
    Á¾µ¿¸Æ(ðûÔÑØæ).
  • end bulb of Krause
  • end dilution value =EDV
    ü¿ÜÈñ¼®Ä¡(ô÷èâýüà·ö·).
  • end feet
  • end group
    ¸»´Ü±â.
  • end organ
    Á¾¸»±â(°ü).
  • end path
    Á¾·Î(ðûÖØ).
  • end piece
    ³¡ºÎºÐ
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • end stage renal disease, ESRD
    ¸»±â½ÅÁúȯ
  • end ureterostomy
    ´Ü´Ü ¿ä°ü·çÁ¶¼º¼ú?
  • end-cutaneous ureterostomy
    ´Ü´Ü ÇǺΠ¿ä°ü·çÁ¶¼º¼ú?
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • end-point mutation
    Á¾¸»Á¡ º¯ÀÌ (ðûØÇïÇܨì¶)
  • end product
    Á¾»ê¹°(ðûß§Úª)
  • end-product inhibition
    Á¾»ê¹° ÀúÇØ (ðûß§ÚªîÁúª)
  • end product repression
    Á¾»ê¹° ¾ïÁ¦ (ðûß§Úªåäð¤)
  • fast-assembly end
    ?
  • frayed end
    Ç®¸° ³¡
  • minus end
    ¸¶À̳ʽº Á¾´Ü(ðýÓ¨)
  • plus end
    Ç÷¯½º Á¾´Ü(ðûÓ®)
  • reducing end
    ȯ¿ø¼º Á¾´Ü(ü½êªàõðûÓ®)
  • slow-assembly end
    ¿Ï¼Ó±¸Ãà ¸»´Ü(èÐáÜϰõéØÇÓ®)
  • sticky end
    Á¡Âø Á¾´Ü (ïÄó·ðûÓ®)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EEA electroencephalic audiometry; end-to-end anastomosis
ES ejection sound; elastic stocking; electrical stimulus, electrical stimulation; electroshock; emergen...
FEP fluorinated ethylene-propylene; free erythrocyte protoporphyrin; front-end processing; front-end pro...
PEEP positive end-expiratory pressure, peak end-expiratory pressure
ter rub [Lat. tere]; terminal [end of chromosome]; terminal or end; ternary; tertiary; three times; thre...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
auto-PEEP Auto-positive end expiratory pressure
B-END Beta-endorphin
beta-END-LI Beta-endorphin-like immunoreactivity
EDV End Diastolic Volume
ESRD End Stage Renal DIsease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • left ventricular end-diastolic volume
    Á ½É½Ç À̿ϱ⸻ ¿ëÀû
  • soft end feel
    ºÎµå·¯¿î Á¾¸»°¨
  • vibrating end
    Áøµ¿ ¸»´ÜºÎ
  • zero end expiratory pressure
    È£±â¸» ¹«¾Ð, È£±â¸» ¹«¿µ¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
supra-acromial <anatomy> Situated above the acromial process of the scapula.
Source: Websters Dictionary
(01 Mar 1998)
blunt-end Refers to double-stranded DNA in which there are no unpaired bases at the end.
(05 Mar 2000)
blunt-end DNA <molecular biology> A fragment of a DNA molecule in which the ends of both strands are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
blunt-end ligation A lab technique to join together two pieces of blunt-end DNA, such as an insert into a cloning vector, which requires the enzyme ligase because there are no single-stranded overhanging ends for the attachment to form more spontaneously, by itself.
(09 Oct 1997)
by-end Private end or interest; secret purpose; selfish advantage.
Alternative forms: bye-end.
(20 Mar 1998)
capped 5'-end A methylated (has a -CH3 attached) guanosine nucleotide attached to the 5'-end (the beginning) of an eukaryotic mRNA, thought to give the mRNA stability.
(09 Oct 1997)
glycosylation end products, advanced Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.
(12 Dec 1998)
root end cyst An inflammatory odontogenic cyst derived histogenetically from Malassez' epithelial rests surrounding the root apex of a nonvital tooth.
Synonym: periapical cyst, radicular cyst, root end cyst.
(05 Mar 2000)
root end granuloma Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.
(12 Dec 1998)
miniature end plate potential <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells.
They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle.
(12 Jan 1998)
positive end-expiratory pressure A technique used in respiratory therapy in which airway pressure greater than atmospheric pressure is achieved at the end of exhalation by introduction of a mechanical impedance to exhalation.
(05 Mar 2000)
skin test end-point titration A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.
(12 Dec 1998)
negative end-expiratory pressure A subatmospheric pressure at the airway at the end of expiration.
(05 Mar 2000)
sternal end of clavicle The enlarged medial end of the clavicle that articulates with the manubrium sterni.
Synonym: extremitas sternalis claviculae, sternal end of clavicle.
(05 Mar 2000)
dead-end host A host from which infectious agents are not transmitted to other susceptible host's.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • end consumer
    ÃÖÁ¾ ¼ÒºñÀÚ
  • end game
    (ü½º,½ÃÇÕÀÇ)ÃÖÁ¾È¸;¸·ÆÇ
  • end line
    ³¡(ÇѰè,°æ°è)À» ³ªÅ¸³»´Â ¼±;(Å״Ͻº,³ó±¸,¹Ì½Ä Ã౸ µîÀÇ)¿£µå ¶óÀÎ
  • end man
    ¿­ ³¡ÀÇ »ç¶÷;¼îÀÇ ¹«´ë ¾ç³¡¿¡ ÀÖ´Â ÈæÀÎ ±¤´ë
  • end matter
    (ÀÎ)Ã¥ÀÇ ºÎ·Ï(ÁÖ¼®,Âü°í ¹®Çå ¸ñ·Ï,»öÀÎ µî)
  • end organ
    (»ý¸®)(½Å°æÀÇ)Á¾¸» ±â°ü;´Ü¸»±â
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • end product
    ¿¬¼Ó º¯È­ÀÇ ÃÖÁ¾°á°ú;ÃÖÁ¾ »ý¼º¹°
  • end rhyme
    (¿î)°¢¿î
  • end run
    ¿£µå·±(°øÀ» °¡Áø ¼±¼ö°¡ ¾Æ±º ¹æ¾îÁøÀÇ Ãø¸éÀ» µ¹¾Æ ÈĹæÀ¸·Î ³ª°¡´Â Ç÷¹ÀÌ)±³¹¦ÇÑ È¸ÇÇ
  • end stop
    ¹®¹Ì ±âÈ£
  • end table
    (¼ÒÆÄ,ÀÇÀÚ °ç¿¡ ³õ´Â)ÀÛÀº Å×À̺í
  • end use
    ÃÖÁ¾ ¿ëµµ
  • end user
    ÃÖÁ¾ ¼ö¿äÀÚ;½Ç¼ö¿äÀÚ
  • end ways
    ³¡À» À§·ÎÇϰí;¼¼·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á